Edex®
(alprostadil for injection)
Edex® is an injectable therapy used to treat erectile dysfunction of neurogenic, vasculogenic, psychogenic or mixed etiology. The active ingredient, alprostadil, widens blood vessels and increases blood flow into the penis. Edex offers a convenient option that starts to take effect in five to 20 minutes.
Edex is for men who do not respond to, or are not candidates for, oral erectile dysfunction therapy.1
Patients who have conditions that might predispose them to priapism or with penile implants should not be treated with Edex.
Patients should seek immediate medical assistance for an erection lasting longer than 6 hours. Use of Edex offers no protection from the transmission of sexually transmitted or blood-borne diseases.
Product Details
➢ FDA approved with over 10 years of patient experience
➢ Convenient single-dose cartridges of
- 10 mcg
- 20 mcg
- 40 mcg
➢ Available in two- and six-cartridge packages
➢ No refrigeration required
➢ Simple, easy-to-follow patient instructions
➢ Carrying case for reusable injection device
Talk to your healthcare provider to see if Edex is right for you.
The most common side effect experienced by patients was penile pain (reported by 31 percent of Edex patients vs. 9 percent of placebo patients in placebo-controlled studies). Only 15 percent of injections were associated with penile pain on a per-injection basis.
1Montorsi F, Salonia A, Deho F, et al. Pharmacological management of erectile dysfunction. BJU Int. 2003;91(5):446-54.
Please see full prescribing information for complete product information.
➢ Download Full Prescribing Information (PDF)
Adobe® Reader® is required to view PDF documents. Click here to download Adobe Reader for FREE.